HAPVIDA ON NM revenue for the last year amounted to 27.38 B BRL, the most of which — 27.40 B BRL — came from its highest performing source at the moment, Gross Consideration, the year earlier bringing 23.47 B BRL. The greatest contribution to the revenue figure was made by Brazil — last year it brought HAPVIDA ON NM 27.38 B BRL, and the year before that — 23.75 B BRL.